Literature DB >> 10704057

Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release.

A El-Shazly1, T Ishikawa.   

Abstract

Eosinophils, chemokines, and neuropeptides are thought to play effector roles in the pathogenesis of allergic diseases such as rhinitis. Eotaxin is a novel C-C chemokine with a potent and relatively specific eosinophil chemoattractant activity that binds selectively to CCR3 receptor, however, its activity in inducing eosinophil granules proteins release is poorly characterized. This study was performed to determine whether eotaxin primes eosinophil exocytosis and whether this co-operates with the sensory neuroimmune-axis. In the present communication, we show that 10 ng/ml eotaxin primed normal human eosinophil for exaggerated eosonophil-derived neurotoxin (EDN) release stimulated by 10(-8) M Substance-P (SP). This novel priming was blocked by; 7B11 and Herbimycin A (HA), the CCR3 antagonist and the tyrosine kinase inhibitor, respectively. SDS-Page studies showed significant tyrosine phosphorylation of several protein residues induced by 10(-8) M SP only after priming with 10 ng/ml eotaxin. These results demonstrate a novel co-operation between eotaxin and SP in inducing eosinophil cytotoxicity, which at least in part involves tyrosine kinases pathway(s).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10704057      PMCID: PMC1781792          DOI: 10.1080/09629359990522

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  5 in total

1.  Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis.

Authors:  E M Minshall; L Cameron; F Lavigne; D Y Leung; D Hamilos; E A Garcia-Zepada; M Rothenberg; A D Luster; Q Hamid
Journal:  Am J Respir Cell Mol Biol       Date:  1997-12       Impact factor: 6.914

2.  Mechanisms involved in activation of human eosinophil exocytosis by substance P: an in vitro model of sensory neuroimmunomodulation.

Authors:  A E el-Shazly; K Masuyama; T Ishikawa
Journal:  Immunol Invest       Date:  1997 Aug-Dec       Impact factor: 3.657

3.  Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro.

Authors:  S Motojima; E Frigas; D A Loegering; G J Gleich
Journal:  Am Rev Respir Dis       Date:  1989-03

4.  Tyrosine phosphorylation is required for eosinophil degranulation induced by immobilized immunoglobulins.

Authors:  M Kato; R T Abraham; H Kita
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

5.  Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils.

Authors:  A El-Shazly; K Masuyama; K Nakano; M Eura; Y Samejima; T Ishikawa
Journal:  Int Arch Allergy Immunol       Date:  1998-09       Impact factor: 2.749

  5 in total
  3 in total

Review 1.  An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis.

Authors:  Zahra Ahmadi; Gholamhossein Hassanshahi; Hossein Khorramdelazad; Nahid Zainodini; Leila Koochakzadeh
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

2.  Mechanisms underlying the inhibitory effects of tachykinin receptor antagonists on eosinophil recruitment in an allergic pleurisy model in mice.

Authors:  Ana Leticia Alessandri; Vanessa Pinho; Danielle G Souza; Maria Salete de A Castro; Andre Klein; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2003-11       Impact factor: 8.739

3.  Unilateral nasal allergic reactions increase bilateral sinus eosinophil infiltration.

Authors:  Fuad M Baroody; Marcella Detineo; Robert M Naclerio
Journal:  J Appl Physiol (1985)       Date:  2013-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.